Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
University of Delaware's Center for Political Communication unveils new vision, goals and leadership
The University of Delaware's Center for Political Communication (CPC) is excited to announce a transformative new chapter with the unveiling of its updated vision, goals and leadership for 2024 and beyond. Since its founding in 2010, the CPC has been at the forefront of innovative public opinion research on politics and media, always with an eye towards protecting and improving American democracy. With this new chapter, the CPC is actively integrating political psychology (the study of how and why people make political judgments and form political beliefs) into the study of public opinion and media effects. “Our vision is responsible democracy-centered journalism informed by our rigorous research on Americans’ thoughts, feelings, knowledge and behaviors,” says Dr. Dannagal Young, incoming Director of the Center for Political Communication. “In a few weeks, will be releasing new data on Americans’ knowledge and beliefs about abortion – an issue on which there are widespread misperceptions. Later this fall we are also launching an interdisciplinary initiative to understand the relationship between Americans’ personal wellbeing and their support for democratic institutions and norms.” By producing high-quality research at the intersection of media, politics and psychology, the CPC strives to elevate public conversations and inform news coverage to improve democratic health. Additionally, the Center seeks to serve as a vital resource for journalists, offering expert commentary and empirical data to encourage democratically responsible journalism. With this new direction comes new leadership, bringing together a team of esteemed scholars from Political Science, Communication and Journalism: Director Dr. Dannagal Young, Professor in the Departments of Communication and Political Science and International Relations, TED speaker, and author of Wrong: How Media, Politics, and Identity Drive our Appetite for Misinformation (Johns Hopkins, 2023) and Irony and Outrage: The Polarized Landscape of Rage, Fear, and Laugher in the U.S. (Oxford, 2020). Areas of Expertise: Misinformation, Political Satire, American Politics, the Psychology of Media Effects. Associate Director Dr. Erin Cassese, Professor in the Departments of Political Science and International Relations, Communication, and Women and Gender Studies, co-author of Abortion Attitudes and Polarization in the American Electorate (Cambridge, 2024). Areas of Expertise: Gender, Abortion, Public Opinion, Campaigns and Elections. Director of Research Dr. Phil Jones, Associate Professor in the Department of Political Science and International Relations, current Editor-in-Chief at Public Opinion Quarterly. Areas of Expertise: Electoral Politics and Public Opinion. Director of Engagement Dr. Lindsay Hoffman, Associate Professor in the Departments of Communication and Political Science and International Relations, and research leader for the American Council of Trustees and Alumni two-year Braver Angels project funded by the John Templeton Foundation. Areas of Expertise: Communication across Difference, Media Technologies, and Political Participation. Delaware Politics Director Dr. Paul Brewer, Professor in the Departments of Communication and Political Science and International Relations, co-author of Science in the Media: Popular Images and Public Perceptions (Routledge, 2021), former editor of the International Journal of Public Opinion Research. Areas of Expertise: Delaware Politics, Media effects, Political and Science Communication, Public Opinion, and Perceptions of Science. Delaware Debate Director: Nancy Karibjanian, Director of the University of Delaware’s Journalism program, faculty member in the Department of Communication, and former Director of the CPC with 30 years of broadcast experience. Areas of Expertise: Broadcast Journalism, and Delaware Debates. The CPC’s goals reflect its commitment to a vibrant and collaborative research environment that engages scholars and students at all levels. The CPC will continue to spearhead interdisciplinary research across the domains of communication, political psychology, public opinion, media effects, and public policy. The Center offers applied research opportunities for both graduate and undergraduate students in communication and political science, as well as an undergraduate minor in political communication, thus mentoring the next generation of scholars and practitioners. The CPC is proud to put its academic research to work in service of American democratic health.
Low Turnout Expected for Updated COVID Vaccine
Dr. Martine Hackett, associate professor and chair of Hofstra’s Department of Population Health, told Newsday that she believes many people will not get the recently updated vaccine for COVID-19. Less than a quarter of adults and less than 15 percent of children received last year’s vaccine. “I would predict that there would be much less of an uptake, in part because folks have gotten COVID in big numbers over the last few months; there was a summer surge. So some people might feel like they don’t need the vaccine because they feel protected from their recent infection,” she said. “But just in general, there’s just a lack of urgency around the need to get the most recent version of the vaccine.” Dr. Hackett's research focuses on public health and health inequities, particularly in the American suburbs and minority communities. She's available to speak with media - simply click on her icon now to arrange an interview today.
National Institutes of Health award $1.827 million for research on collective cell migration
Priscilla Hwang, Ph.D., assistant professor in the Department of Biomedical Engineering at Virginia Commonwealth University, has received a National Institutes of Health grant for $1.827 million over five years. The award from the National Institute of General Medical Sciences will support Hwang’s innovative research project “Dissecting mechanisms of collective migration” and provide mentorship for student researchers from the high school to graduate level. Collective migration, where groups of cells move together in a coordinated manner, is critical for the successful development of tissues and plays a vital role in wound healing, metastasis, and other biological processes. Dysregulation in collective migration is often linked to developmental abnormalities and disease progression. Despite its importance, the mechanics and mechanisms driving collective migration remain poorly understood. The project is organized around three primary goals: Investigate the effect of biomechanical cues to activate leader cells and directional collective migration: Understand how biomechanical signals activate leader cells to guide the migration of cell groups. Elucidate which and how leader cell mechanics are responsible for leader cell development: Identify the specific mechanical properties and behaviors that enable leader cells to emerge and lead the collective migration process. Examine the role of cell junctional forces in collective migration: Explore how the forces at cell contacts contribute to the overall migration and coordination among cells. Hwang will leverage her expertise in 3D microphysiological systems to study collective migration in dynamic, physiologically relevant environments. Her work aims to uncover the mechanisms by which leader cells sense and respond to mechanical forces in their environment, driving the collective migration of cells. “Our understanding of collective migration, especially the mechanics and mechanisms driving this phenomenon, is very limited,” Hwang said. “Our proposal will significantly accelerate our progress toward a comprehensive understanding of collective migration and lay the foundation for advancing treatment for developmental abnormalities or diseases.” The NIH grant will also expand student research and mentoring opportunities. “This Maximizing Investigators Research Award (MIRA) only goes to the most highly talented and promising investigators, and Dr. Hwang is most deserving,” said Rebecca L. Heise, Ph.D., Inez A. Caudill, Jr. Distinguished Professor and chair of the Department of Biomedical Engineering . “The award will provide support for undergraduate and predoctoral research opportunities in this important area of fundamental research that has an impact on neonatal development, cancer, and fibrotic disease.” To ensure diverse perspectives are considered throughout the project, Hwang said students from diverse populations will be recruited, including underrepresented minorities, women, and first-generation college students. “Further, we will continue to share our passion for science with the community through developing hands-on outreach activities based on our research findings,” she added.
ChristianaCare Nurses Inducted as American Academy of Nursing Fellows
In recognition of their extraordinary impact on the nursing profession, two ChristianaCare nurses have been named as Fellows of the American Academy of Nursing (AAN). This prestigious recognition highlights their significant contributions to nursing leadership, innovation and health care policy. Michelle Collins, DNP, APRN, CNS, ACNS-BC, NPD-BC, NEA-BC, LSSBB, currently serves as vice president of Nursing Professional Excellence at ChristianaCare. Throughout her accomplished 30-year career, Collins has played a crucial role in improving how nurses practice and learn. Her leadership was significant in achieving ChristianaCare’s third Magnet® designation, highlighting her commitment to excellence. Collins’ initiatives, including pioneering a Virtual Acute Care Nursing model and securing a $1.5 million grant for nursing technology integration, have set new standards in health care innovation. Danielle Sarik, Ph.D., APRN, CPNP-PC, is a nurse scientist consultant at ChristianaCare. Her research contributions have been integral in shaping policies that improve health care outcomes for children and families. Sarik is renowned for developing and implementing the Baby Steps model, recognized by the AAN as an Edge Runner designee. This pioneering transition of care approach addresses health equity for neonatal patients and families following discharge from the neonatal intensive care unit. “Induction into the Academy represents the highest honor in nursing,” said AAN President Linda Scott. “Earning the Fellow of the American Academy of Nursing (FAAN) credential is a significant recognition of one’s accomplishments and signifies the future impact they will make in collaboration with their colleagues in the Academy.”
‘You Can Do and Be Anything Coming From an HBCU’
A late July dinner was the finale to her second internship with ChristianaCare for Tania Paden. Her eight weeks at Christiana Hospital had left her feeling more confident in herself and excited to continue exploring direct patient care as she prepares to head back to Delaware State University in the fall. “I learned how to be more comfortable with direct patient care and communicate with the patients,” Paden said. “My favorite thing would have to be going to tour the different units and getting shadowing experiences throughout the hospital.” Paden is one of 10 Future of Health Scholarship Program recipients at ChristianaCare. Graduates from Delaware high schools attending Historically Black Colleges and Universities (HBCUs) were each awarded a $12,500 annual scholarship and a paid summer internship in 2021 each year until they graduate. The program, a partnership between ChristianaCare and the HBCU Week Foundation, is designed to help support HBCU students as they pursue degrees in health care. Teachable moments and big opportunities Paden’s enthusiasm is shared by Natalie Torres, director of Inclusion & Diversity at ChristianaCare, who oversees the scholarship program. “This experience is so much more than offering the scholarship funding,” Torres said. “It’s the time, it’s those quiet moments in-between meetings and their experiences where the teachable moments really take place. “When they come to us, we really want to lock into their lived experiences, and not only make sure they can thrive at ChristianaCare, but in life.” With these scholarships and other community-based endeavors, ChristianaCare continues to work to build a diverse workforce and represent its communities. Forbes recently listed ChristianaCare as one of America’s Best Employers for Diversity for the fourth year in a row. Although she is a young intern herself, Aniyah Barnett, a rising biochemistry junior at Hampton University, jumped at the chance to help make new caregivers feel comfortable at ChristianaCare. She played a key role welcoming medical and dental residents to campus. “My favorite project was probably the new resident orientation,” Barnett said. “I spent time getting all the new residents together, making sure they have all the information they need, and getting to meet them!” A pathway to medicine For Ashley Christopher, Esq., founder and CEO of HBCU Week Foundation, these scholarships mean a lot. Ten years ago, Christopher had a stroke that left her feeling scared and alone as she lay in hospital. Her cardiologist, a Black woman, was the only one who made her feel heard, she told the students during their summer-end dinner. With IT experiences gained at ChristianaCare, Future of Health scholar Solomon Devard is thinking about continuing on that path to become a system administrator for a big corporation. “She was the only one who made me feel safe, secure and seen during a time where I was questioning life as I knew it,” Christopher said. “You can do and be anything coming from an HBCU. This scholarship gives students who want to go to HBCUs a pathway to the field of medicine for more people who look like me to tend to the care of patients.” The HBCU Week Foundation creates opportunities through coaching and scholarships for students who want to attend HBCUs. To support these efforts, ChristianaCare committed $500,000 to providing financial and networking support, and hands-on experiences for HBCU students. “These students are energized, they’re talented, and I’m so excited for the next step,” Christopher said. “I just feel so happy to be a part of that process.”
#ExpertSpotlight: Mpox - are we ready?
As global health continues to navigate the challenges of infectious diseases, the re-emergence and spread of Monkeypox (now known as Mpox) underscores the ongoing threat posed by zoonotic viruses. This topic is critical not only because of its public health implications but also due to the broader issues it raises concerning global preparedness, vaccination strategies, and the socio-economic impact of outbreaks. The resurgence of Mpox, particularly in non-endemic regions, highlights the need for vigilant public health measures and cross-border cooperation to contain its spread. As the world remains focused on preventing another global health crisis, Mpox serves as a pertinent reminder of the interconnectedness of human, animal, and environmental health. Key story angles include: Vaccination strategies and public health response: Explore how different countries are deploying vaccines to control Mpox, and the challenges faced in achieving widespread immunity. Global health security and disease surveillance: Investigate the effectiveness of international disease surveillance systems in detecting and responding to outbreaks like Mpox, and the lessons learned from the COVID-19 pandemic. The role of zoonotic diseases in global pandemics: Examine the origins of Mpox as a zoonotic disease, and the broader implications for how human activities are influencing the spread of diseases from animals to humans. Impact on marginalized communities: Discuss how Mpox disproportionately affects marginalized populations, including those with limited access to healthcare, and the importance of equitable health interventions. Public communication and misinformation: Analyze the role of media and public health authorities in communicating accurate information about Mpox, combating misinformation, and educating the public about prevention and treatment. Economic implications of outbreaks: Examine the economic impact of Mpox outbreaks, particularly in regions where tourism, trade, and healthcare resources are significantly affected by public health crises. By addressing these angles, journalists can provide critical insights into the multifaceted impact of Mpox on global health, public safety, and socio-economic stability, contributing to a more informed and prepared public. Connect with an expert about Mpox: To search our full list of experts visit www.expertfile.com Photo Credit: National Institute of Allergy and Infectious Diseases
Earlier this year, the Drug Enforcement Agency (DEA) announced that it would move marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA), greatly reducing the restrictions on the drug. It represents a historic change in federal marijuana policy and a watershed moment for generations of activists that have sought legalization on a national level. While many advocates believe the shift bodes well for efforts to relax controls on other Schedule I drugs—including promising psychedelics like psilocybin, MDMA, and LSD– Vanderbilt Law professor Robert Mikos argues that the marijuana rescheduling decision will not pave the way for rescheduling any other drug. Mikos explains that the decision preserves the barriers that make it virtually impossible to remove drugs from Schedule I. He labels those barriers the “tyrannies of scheduling.” In his paper “Marijuana and the Tyrannies of Scheduling,” forthcoming in Fordham Law Review, Mikos lays out the core challenges posed by the existing scheduling process and offers a solution that would lead to “more rational scheduling decisions that better reflect the benefits and dangers of controlled substances, as Congress intended.” The Role of Currently Accepted Medical Use in Scheduling Decisions The CSA creates five Schedules (I-V). Scheduling dictates how a drug is regulated under the statute. Schedule I drugs are subject to the most restrictive controls, and those controls are steadily relaxed as one moves down the schedules. Congress made all the initial scheduling decisions when it passed the CSA in 1970, but it also empowered the DEA, working in conjunction with the Department of Health and Human Services (HHS), to reschedule drugs based on new information acquired after the passage of the statute. Agency scheduling decisions are supposed to be based on three core characteristics of a drug: its abuse potential, its dependence liability, and whether it has a currently accepted medical use (CAMU). Unfortunately, these characteristics do not always suggest the same schedule for a drug. But as Mikos explains, the DEA has grossly simplified the scheduling process by suggesting that CAMU determinations should trump all other considerations. In particular, the agency has insisted that a drug with no CAMU must be placed on Schedule I, regardless of its abuse potential or dependence liability. According to Mikos, the DEA’s simplification of the scheduling process places tremendous weight on agency CAMU determinations and how the agency chooses to define this particular scheduling criteria. The Tyranny of Science In the past, the DEA insisted that the only way to demonstrate that a drug has a CAMU was by completing multiple controlled trials (RCTs) demonstrating that a drug is effective at treating some medical indication, the same requirement for new drug approval under the Food, Drug and Cosmetic Act. As Mikos has noted in his past work, completing such trials is “notoriously expensive and time-consuming,” requiring strict parameters and a large number of participants. The challenge is even more daunting for drugs already on Schedule I, because the CSA restricts research on such drugs. Due to regulatory restrictions, marijuana advocates have struggled to complete even a single RCT demonstrating marijuana’s medical efficacy. Indeed, in the past 50 years, only one Schedule I drug (Epidiolex) has ever been able to satisfy the DEA’s CAMU test, leading Mikos to label the agency’s science-focused approach the “Tyranny of Science.” The Tyranny of the Majority In 2023, however, HHS devised an alternative CAMU test that emphasizes practical experience over scientific research. “Because more than 30,000 health care practitioners (HCPs) had already recommended the drug to their patients in the thirty-eight states with medical marijuana laws,” Mikos explains, “the agency concluded there was enough clinical experience to demonstrate that marijuana has a CAMU and thus could be rescheduled.” But while this alternative test does not require completing RCTs – and thereby eliminates the Tyranny of Science – Mikos demonstrates that it is no less tyrannical than the DEA’s original CAMU test. According to Mikos, the alternative CAMU test simply “imposes a different form of tyranny: the Tyranny of the Majority.” He explains that to accumulate the clinical experience needed to satisfy the new test, advocates must convince popular majorities in a substantial number of states to legalize medical use of a drug. It took decades to build the public support necessary to do that for marijuana, and Mikos points out that no other Schedule I drug currently commands the same level of public support as marijuana. “Despite growing interest in the therapeutic value of [psychedelics, . . . less than a quarter of all Americans support legalizing psychedelics like psilocybin,” Mikos writes. “By comparison, 90% of Americans support legalizing medical marijuana.” What is more, even if large numbers of states were to legalize medical use of a substance like psilocybin or MDMA, advocates will also have to convince large numbers of patients, their health care practitioners (HCPs), and their suppliers to risk federal sanctions in order to accumulate the clinical experience HHS demands to satisfy the new CAMU test. “While marijuana was finally able to run the gauntlet, no other Schedule I is likely to replicate that feat anytime soon. Other promising Schedule I drugs like psilocybin, MDMA, and LSD are likely to remain trapped on that schedule for the foreseeable future,” the paper states. A New Way Forward Mikos argues that the agencies did not need to create a new CAMU test to reschedule marijuana. He suggests that the DEA has placed too much emphasis on CAMU in scheduling decisions. The DEA “has no authority, and no good reason, to hold (or place) a drug on Schedule I solely because the drug lacks a currently accepted medical use.” Indeed, Mikos suggests the agency’s emphasis on CAMU runs contrary to the text of the CSA and provides insufficient information about a drug’s benefits and risks to make sensible scheduling decisions. Rather than propose yet another, less tyrannical CAMU test, Mikos suggests that the DEA should instead take a more flexible approach to scheduling, one that considers all 3 criteria – a drug’s abuse potential, its dependence liability, and whether or not it has a currently accepted medical use (CAMU)—to determine where a drug belongs among the statute’s five schedules. “Although my approach would not make it any easier to demonstrate CAMU, it would reduce the dominant influence CAMU determinations now wield over scheduling decisions,” Mikos concludes. It would enable the agency to remove drugs like marijuana, psilocybin, or MDMA from Schedule I, even if they lack a currently accepted medical use, if their abuse potential and dependence liability so warrant. “As a result,” he notes, “my approach would foster more rational administrative scheduling decisions going forward.”
University of Delaware experts share insights and strategies for navigating the upcoming school year
The College of Education and Human Development in the University of Delaware has a number of stories and experts for the upcoming school year. Stories Bridging the language gap: How AWE software fosters inclusivity for English Language Learners and Non-English Language Learners alike Creating a mindful classroom: Tips for teachers on how to have a peaceful transition into the 2024-2025 school year Empowering Black and Latinx Boys in Their Postsecondary Journeys: The Role of School Communities UD assistant professor Eric Layland shares new research on LGBTQ+ developmental milestones and supporting LGBTQ+ youth University of Delaware assistant professor explores the tensions between hopes and expectations in vocational planning for autistic young adults Experts Allison Karpyn – an associate professor who can speak to topics related to hunger, obesity, school food, supermarket access, and food insecurity. She has spoken extensively about food in schools and can offer context to those subjects. Roderick Carey – an assistant professor whose current interdisciplinary research serves to make sense of the school experiences of black and Latino adolescent boys and young men in urban contexts. He can also talk about teacher education as it relates to men in the field/the impact of male teachers. To contact Karpyn or Carey, click their profiles. More experts... If you would like to pursue any of these stories or speak to any of the following experts, they are all willing and excited to chat. Contact mediarelations@udel.edu to speak to them. Eric Layland – an assistant professor who can speak about LGBTQ+ student experiences from a research perspective. His work bridges LGBTQ+ developmental research to community impact through developmentally-informed, affirmative interventions. Sarah Mallory – an assistant professor who specializes in special education with a special focus on autism and other intellectual and developmental disabilities. She also works within the Center for Disabilities Studies. Sarah Curtiss – an assistant professor who specializes in special education with a special focus on autistic youth. Brittany Zakszeski – an assistant professor and nationally certified school psychologist, licensed psychologist and behavior analyst. She focuses on student and teacher mental health and can comment on what concealed weapons carried by teachers can do for the mental wellbeing of both students and teachers. Lauren Bailes – an associate professor who focuses on the ways in which organizational, social-cognitive, and leadership theory unite to promote the success of school leaders and K-12 students. Bryan VanGronigen – an assistant professor who specializes in organizational resilience and change management in K-12 schools with specific interest areas in efforts to improve schools, the preparation and professional development of educational leaders and educational policy analyses. Lynsey Gibbons – an associate professor specializing in mathematics education, in teacher professional learning and school partnerships across content areas. Contact mediarelations@udel.edu to speak to these experts or for more information on the stories above.
For the fifth consecutive year, ChristianaCare’s Center for Heart & Vascular Health has earned the premier recognition from The American College of Cardiology (ACC) – the HeartCARE Center National Distinction of Excellence award – for its commitment to comprehensive, high quality cardiovascular care. ChristianaCare was the first hospital system in Delaware and one of only a handful in the U.S. to attain this recognition when it was first awarded in 2020 from the ACC, a nonprofit medical association representing more than 50,000 cardiovascular specialists. “We are proud to be a regional leader for cardiovascular care with the most advanced medical, surgical and minimally invasive specialty care, technology and research,” said Kirk Garratt, M.D., medical director of ChristianaCare’s Center for Heart & Vascular Health. “Congratulations to our entire team and all who collaborate seamlessly to deliver care 24/7. As a result, those living in Delaware and neighboring states can receive the highest quality cardiovascular care from the Center for Heart & Vascular Health.” Hospitals that have earned an ACC HeartCARE Center designation have met a set of criteria, including participating in at least two ACC accreditation services programs, national cardiovascular data registries and targeted quality improvement campaigns designed to close gaps in guideline-based care. In addition to being a current recipient of the HeartCARE Center designation, ChristianaCare participates in the ACC’s chest pain MI with PCI (heart attack with angioplasty) and resuscitation accreditation, cath lab accreditation and the Society of Thoracic Surgeon database. “ChristianaCare has demonstrated its commitment to providing the community with excellent heart care,” said Deepak L. Bhatt, M.D., MPH, FACC, chair of the ACC accreditation management board. “ACC accreditation services is proud to award the Center for Heart & Vascular Health with the HeartCARE Center designation.” Hospitals receiving the HeartCARE Center designation have demonstrated their commitment to consistent, high-quality cardiovascular care through comprehensive process improvement, disease and procedure-specific accreditation, professional excellence and community engagement. ChristianaCare has proven to be a forward-thinking institution with goals to advance the cause of sustainable quality improvement. The Center for Heart & Vascular Health is among the largest, most capable regional heart centers on the East Coast. It is among the few centers in the region that integrates cardiac surgery, vascular surgery, vascular interventional radiology, cardiology and interventional nephrology in a single location. Its expert clinical staff performed nearly 200,000 patient procedures last year.
Saving Lives, One Device at a Time: Clinical Engineering
Behind every health care provider, or perhaps already in the palms of their hands, is a piece of equipment necessary to their patient’s health and survival. Modern medical treatment relies on complex equipment to keep patients alive and healthy during procedures and recovery. Take live-saving equipment such as telemetry monitors, MRI machines and ventilators as just a few examples. But what happens when all that equipment needs repair? Enter ChristianaCare’s clinical engineering technicians. This team of 35 employees — one of the largest clinical engineering teams in the nation — is responsible for overseeing the care, testing and repair of the roughly 50,000 pieces of medical equipment in use throughout the ChristianaCare system. The Clinical Engineering team is overseen by Director Blake Collins, MBA, CBET, CHTM, nationally recognized for excellence in the profession. He brings two decades of experience as a clinical engineer in the United States Navy, seven of which were served with the U.S. Marine Corps, to his role. His team has won numerous trade industry awards for its success as a “solutions provider” for the health system. "Think of health care as a triangle,” said Collins. “You have the patient, the provider and the equipment. You can’t have successful health care delivery without those three elements.” Begun in the 1970s as the hospital system’s “TV repair shop,” he joked, the Clinical Engineering department evolved dramatically after subsequent national developments in electrical safety testing and oversight for the care and functionality of medical equipment. ‘Everyone truly cares’ Today, the Clinical Engineering department maintains close to 50,000 pieces of medical equipment throughout the ChristianaCare system, including its three hospitals and all its imaging centers. “From thermometers to linear accelerators, MRIs, CTs — we manage all of it,” Collins said. Last year, the team completed 25,000 work orders, or roughly 2,100 per month. “We get to help people in so many different ways,” said John Learish, Clinical Engineering manager. Samantha Daws, Clinical Engineering supervisor, echoed the sentiment. “The Clinical Engineering Department within ChristianaCare is the most talented group of technicians I have ever had the privilege to work with,” she said. “Everyone truly cares about keeping the equipment working to ensure all caregivers have what is needed to provide quality health care to our community.” Saving lives, one device at a time What’s so important about what Clinical Engineering offers to ChristianaCare? In short: Anyone could need medical care at any time, and if medical equipment were out of commission or wrongly calibrated, lives would be at stake. Collins recalls a pivotal moment during his tenure in the Navy, when he needed an emergency appendectomy while stationed on board an aircraft carrier. “I was the only biomedical technician on the ship,” he said. “And the doctor doing the procedure asked me, jokingly, ‘Hey Collins, is this equipment going to work?’ “He was kidding, but it’s true that we never know when we or a loved one is going to end up under the equipment that we work on as engineers.” This experience gained new significance for Collins after successful open-heart surgery at ChristianaCare in 2022 — followed by his mother, who had the same procedure, also successfully, in 2023. “I had not one inkling or shadow of a doubt that the equipment was going to work fine,” he said. “You never know who will end up needing care. So we take it very, very seriously.” Icon in the field For his outstanding service as Director of Clinical Engineering at ChristianaCare, Collins was presented with the 2024 John D. Hughes Iconoclast Award from the Association for the Advancement of Medical Instrumentation (AAMI), a career-marking honor in health care technology management. The award recognizes innovation and leadership in the field; for Collins, it shows how well the Clinical Engineering team works together to deliver safe medical equipment across the ChristianaCare system. “Blake has been a relentless advocate for ChristianaCare,” read his nomination. “He has implemented numerous initiatives and processes to improve his department … and work smarter through the use of technology and automation.” The next time you see a ChristianaCare provider pick up an instrument or turn on a machine, think about the Clinical Engineering team — and rest assured that your equipment is ready to go.
